Agency Forms Undergoing Paperwork Reduction Act Review, 78971-78973 [2022-28005]
Download as PDF
<![CDATA[
78971
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form No. & name
57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction.
57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction.
57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic
Transfusion Reaction.
57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion
Reaction.
57.313 Hemovigilance Adverse Reaction—Infection ..............................
57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ..
57.315 Hemovigilance Adverse Reaction—Transfusion Associated
Dyspnea.
57.316 Hemovigilance Adverse Reaction—Transfusion Associated
Graft vs. Host Disease.
57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute
Lung Injury.
57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload.
57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction.
57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction
57.400 Outpatient Procedure Component—Annual Facility Survey ......
57.401 Outpatient Procedure Component—Monthly Reporting Plan .....
57.402 Outpatient Procedure Component Same Day Outcome Measures.
57.403 Outpatient Procedure Component—Monthly Denominators for
Same Day Outcome Measures.
57.404 Outpatient Procedure Component—SSI Denominator ...............
57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ..
57.500 Outpatient Dialysis Center Practices Survey ..............................
57.501 Dialysis Monthly Reporting Plan .................................................
57.502 Dialysis Event .............................................................................
57.503 Denominator for Outpatient Dialysis ...........................................
57.504 Prevention Process Measures Monthly Monitoring for Dialysis
57.505 Dialysis Patient Influenza Vaccination ........................................
57.506 Dialysis Patient Influenza Vaccination Denominator ..................
57.507 Home Dialysis Center Practices Survey .....................................
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities.
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities.
Weekly Resident Influenza Vaccination Cumulative Summary for
Long-Term Care Facilities.
Annual Healthcare Personnel Influenza Vaccination Summary .............
Monthly Survey Patient Days & Nurse Staffing ......................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–28004 Filed 12–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–23–1318]
TKELLEY on DSK125TN23PROD with NOTICE
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Requirement
for Proof of COVID–19 Vaccination for
Noncitizen, Nonimmigrant Air
Passengers Arriving into the United
States from a Foreign Country’’ to the
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
(in hours)
Average
burden per
response
(in hours)
500
1
20/60
500
2
20/60
500
4
20/60
500
1
20/60
500
500
500
1
1
1
20/60
20/60
20/60
500
1
20/60
500
1
20/60
500
2
20/60
500
1
20/60
500
700
700
200
1
1
12
1
20/60
10/60
15/60
40/60
200
400
40/60
700
700
7,200
7,200
7,200
7,200
1,730
615
615
430
125
100
5
1
12
30
30
12
50
5
1
52
40/60
40/60
12/60
5/60
25/60
10/60
75/60
10/60
10/60
30/60
60/60
1,200
52
60/60
2,500
52
60/60
5,000
2,500
1
12
120/60
60/60
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 5, 2022 to obtain
comments from the public and affected
agencies. CDC received 5,935 comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
E:\FR\FM\23DEN1.SGM
23DEN1
78972
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Requirement for Proof of COVID–19
Vaccination for Noncitizen,
Nonimmigrant Air Passengers Arriving
into the United States from a Foreign
Country (OMB Control No. 0920–1318,
Exp. 12/31/2022)—Extension—National
Center for Emerging Zoonotic and
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ)
requests a two-year Extension for the
information collection: Requirement for
Proof of COVID–19 Vaccination for
Noncitizen, Nonimmigrant Air
Passengers Arriving into the United
States from a Foreign Country. This
information collection is necessary to
implement the Presidential
Proclamation Advancing Safe
Resumption of Global Travel During the
COVID–19 Pandemic and CDC’s
Amended Order Implementing
Presidential Proclamation on Advancing
Safe Resumption of Global Travel
During the COVID–19 Pandemic.
Pursuant to Sections 1182(f) and
1185(a)(1) of Title 8, and Section 301 of
Title 3, United States Code, on October
25, 2021, the President issued a
Proclamation (‘‘the Proclamation’’)
titled, ‘‘Advancing the Safe Resumption
of Global Travel During the COVID–19
Pandemic.’’ With this Proclamation, the
President implemented a global
suspension and limitation on entry for
noncitizens who are nonimmigrants
(‘‘noncitizen nonimmigrants’’) seeking
to enter the United States by air travel
and who are not fully vaccinated against
COVID–19. The Proclamation directs, in
part, the Secretary of Health and Human
Services (HHS), through the Director of
the Centers for Disease Control and
Prevention (CDC), to implement the
Proclamation as it applies to public
health in accordance with appropriate
public health protocols and consistent
with CDC’s independent public health
judgment.
CDC issued the Order Implementing
the Presidential Proclamation on
Advancing Safe Resumption of Global
Travel During the COVID–19 Pandemic
on October 25, 2021. Beginning on
November 8, 2021, CDC’s Order
required noncitizen nonimmigrants to
show proof of being fully vaccinated
against COVID–19 with: (1) one of the
vaccines approved (or authorized for
emergency use) by the U.S. Food and
Drug Administration (FDA); (2) a
vaccine listed for emergency use by the
World Health Organization (WHO); or
(3) a combination of vaccines as
specified in CDC Technical Instructions.
Air passengers who are noncitizen
nonimmigrants must provide proof of
COVID–19 vaccination and attest to the
truthfulness of the proof of vaccination.
Airlines must also confirm that the
proof of vaccination matches the
passengers’ identity, as instructed by the
airline before being allowed to board a
flight to the United States. The Order
allows some exceptions to this
requirement. Most categories of
exceptions require the individual to
attest to taking certain measures after
U.S. arrival, specifically, getting tested
3–5 days after arrival and isolating if
they test positive or develop symptoms.
An additional category of exceptions
requires the individual to attest to
getting fully vaccinated against COVID–
19 if staying more than 60 days.
CDC issued an amended Order on
October 30, 2021, and on April 4, 2022.
The Amended Vaccination Order signed
on April 4, 2022 superseded the
previous Order signed by the CDC
Director on October 30, 2021, and
continues to implement the President’s
direction. CDC requests OMB approval
for an estimated 68,005,000 annual
burden hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Noncitizen Nonimmigrant Air Passenger ........
Section 2 of Combined Passenger Disclosure and Attestation to the United States
of America.
Combined Passenger Disclosure and Attestation to the United States of America.
Request Humanitarian or Emergency Exception to Proof of Vaccination Requirement—
(No form).
Air Travel Illness or Death Investigation or
Traveler Follow-up Form.
Airline Desk Agent ..........................................
TKELLEY on DSK125TN23PROD with NOTICE
Number of
respondents
Type of respondent
Noncitizen Nonimmigrant Air Passenger ........
Air Traveler (for illness or death investigation)
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
60,000,000
1
1
60,000,000
1
8/60
1,290
1
2
10,000
1
15/60
E:\FR\FM\23DEN1.SGM
23DEN1
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–28005 Filed 12–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Center
for Preparedness and Response
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, Center for
Preparedness and Response (BSC, CPR).
This is a virtual meeting that is open to
the public. The number of attendees is
limited only by the number of internet
conference accesses available, which is
500. Pre-registration is required by
accessing the link in the addresses
section below. Time will be available for
public comment.
DATES: The meeting will be held on
January 23, 2023, from 1 p.m. to 3 p.m.,
EST.
ADDRESSES: Zoom virtual meeting. If
you wish to attend the virtual meeting,
please pre-register by accessing the link
at: https://cdc.zoomgov.com/webinar/
register/WN_
KQGdJ4e4TYWCBzedl1omJg.
Instructions to access the meeting will
be provided in the link following
registration.
SUMMARY:
TKELLEY on DSK125TN23PROD with NOTICE
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Management Analyst,
Office of Science and Public Health
Practice, Center for Preparedness and
Response, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H21–6, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
7450; Facsimile: (678) 669–1667; Email:
DOuisley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, Center for Preparedness and
Response (BSC, CPR) is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services; the Assistant Secretary
for Health; the Director, Centers for
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
Disease Control and Prevention; and the
Director, Center for Preparedness and
Response, concerning strategies and
goals for the programs and research
within the agency and CPR, monitoring
the overall strategic direction and focus
of the CPR Divisions and Offices, and
administration and oversight of peer
review for CPR scientific programs. For
additional information about the Board,
please visit: https://www.cdc.gov/cpr/
bsc/index.htm.
Matters to be Considered: The agenda
will include: (1) an update on the CDC
Moving Forward initiative; and (2) a
BSC, CPR health equity discussion.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–28001 Filed 12–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Placement and Transfer of
Unaccompanied Children Into Office of
Refugee Resettlement Care Provider
Facilities (OMB #: 0970–0554)
Office of Refugee Resettlement,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:
The Office of Refugee
Resettlement (ORR), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is inviting public
comments on revisions to an approved
information collection. The request will
allow the Unaccompanied Children
(UC) Program to ensure that UC are
placed in foster homes that meet their
individual needs and ensure continuity
of services.
SUMMARY:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
78973
Comments due within 60 days of
publication. In compliance with the
requirements of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Identify all requests by the
title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: ORR is proposing the
following revisions to its Long-Term
Foster Care Placement Memo (Form P–
5):
• Change the title to ‘‘CommunityBased Care Placement Memo’’ and
update the term ‘‘long-term foster care’’
to ‘‘community-based care’’ throughout
the memo. This term is more in line
with terminology currently used in
domestic child welfare programs and
will be inclusive of ORR long-term
foster care and transitional foster care
programs.
• Increase the number of respondents
and number of responses per
respondent to include transitional foster
care programs (in addition to long-term
foster care programs).
• Update instructions on which fields
are completed for initial placements and
which are completed for transfers
within the community-based care
program.
• Reword some fields and
instructions for clarity.
• Add field to capture the facility
name for children placed in an out-ofnetwork community-based care
program.
• Separate fields that capture contact
information for the foster family or
group home into separate subsections
and expand the fields to capture
additional contact information (e.g.,
phone or email) in addition to name and
address.
For information about all currently
approved forms under this OMB
number, see: https://www.reginfo.gov/
public/do/PRAViewICR?ref_
nbr=202210-0970-008.
Respondents: ORR grantee and
contractor staff, UC, and other federal
agencies.
DATES:
Annual Burden Estimates
Note: These burden estimates include
burden related to the revisions to Form
P–5 described above and currently
approved forms for which we are not
proposing any changes.
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Pages 78971-78973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28005]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-23-1318]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Requirement for Proof of COVID-19
Vaccination for Noncitizen, Nonimmigrant Air Passengers Arriving into
the United States from a Foreign Country'' to the Office of Management
and Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 5, 2022 to obtain comments from the
public and affected agencies. CDC received 5,935 comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary
[[Page 78972]]
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Requirement for Proof of COVID-19 Vaccination for Noncitizen,
Nonimmigrant Air Passengers Arriving into the United States from a
Foreign Country (OMB Control No. 0920-1318, Exp. 12/31/2022)--
Extension--National Center for Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ) requests a two-year Extension
for the information collection: Requirement for Proof of COVID-19
Vaccination for Noncitizen, Nonimmigrant Air Passengers Arriving into
the United States from a Foreign Country. This information collection
is necessary to implement the Presidential Proclamation Advancing Safe
Resumption of Global Travel During the COVID-19 Pandemic and CDC's
Amended Order Implementing Presidential Proclamation on Advancing Safe
Resumption of Global Travel During the COVID-19 Pandemic.
Pursuant to Sections 1182(f) and 1185(a)(1) of Title 8, and Section
301 of Title 3, United States Code, on October 25, 2021, the President
issued a Proclamation (``the Proclamation'') titled, ``Advancing the
Safe Resumption of Global Travel During the COVID-19 Pandemic.'' With
this Proclamation, the President implemented a global suspension and
limitation on entry for noncitizens who are nonimmigrants (``noncitizen
nonimmigrants'') seeking to enter the United States by air travel and
who are not fully vaccinated against COVID-19. The Proclamation
directs, in part, the Secretary of Health and Human Services (HHS),
through the Director of the Centers for Disease Control and Prevention
(CDC), to implement the Proclamation as it applies to public health in
accordance with appropriate public health protocols and consistent with
CDC's independent public health judgment.
CDC issued the Order Implementing the Presidential Proclamation on
Advancing Safe Resumption of Global Travel During the COVID-19 Pandemic
on October 25, 2021. Beginning on November 8, 2021, CDC's Order
required noncitizen nonimmigrants to show proof of being fully
vaccinated against COVID-19 with: (1) one of the vaccines approved (or
authorized for emergency use) by the U.S. Food and Drug Administration
(FDA); (2) a vaccine listed for emergency use by the World Health
Organization (WHO); or (3) a combination of vaccines as specified in
CDC Technical Instructions.
Air passengers who are noncitizen nonimmigrants must provide proof
of COVID-19 vaccination and attest to the truthfulness of the proof of
vaccination. Airlines must also confirm that the proof of vaccination
matches the passengers' identity, as instructed by the airline before
being allowed to board a flight to the United States. The Order allows
some exceptions to this requirement. Most categories of exceptions
require the individual to attest to taking certain measures after U.S.
arrival, specifically, getting tested 3-5 days after arrival and
isolating if they test positive or develop symptoms. An additional
category of exceptions requires the individual to attest to getting
fully vaccinated against COVID-19 if staying more than 60 days.
CDC issued an amended Order on October 30, 2021, and on April 4,
2022. The Amended Vaccination Order signed on April 4, 2022 superseded
the previous Order signed by the CDC Director on October 30, 2021, and
continues to implement the President's direction. CDC requests OMB
approval for an estimated 68,005,000 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Noncitizen Nonimmigrant Air Passenger. Section 2 of Combined 60,000,000 1 1
Passenger Disclosure
and Attestation to the
United States of
America.
Airline Desk Agent.................... Combined Passenger 60,000,000 1 8/60
Disclosure and
Attestation to the
United States of
America.
Noncitizen Nonimmigrant Air Passenger. Request Humanitarian or 1,290 1 2
Emergency Exception to
Proof of Vaccination
Requirement--(No form).
Air Traveler (for illness or death Air Travel Illness or 10,000 1 15/60
investigation). Death Investigation or
Traveler Follow-up Form.
----------------------------------------------------------------------------------------------------------------
[[Page 78973]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-28005 Filed 12-22-22; 8:45 am]
BILLING CODE 4163-18-P
